Text size: AAA

References for "More evidence on risks of antipsychotics in adults"

Next Article:

Did you know?

You can get instant online access to all of the articles from the April 2009 issue of Harvard Mental Health Letter for only $5.

If you want a button/link to remove the box (not sure if you do or not...), it would look like this: Cancel

Already a subscriber? Login for complete instant access.

Print Article

Ballard C, et al. “The Dementia Antipsychotic Withdrawal Trial (DART-AD): Long-Term Follow-Up of a Randomised Placebo-Controlled Trial,” Lancet Neurology (Feb. 2009): Vol. 8, No. 2, pp. 151-57. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19138567

Ray WA, et al. “Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death,” New England Journal of Medicine (Jan. 15, 2009): Vol. 360, No. 3, pp. 225–35. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19144938

Schneeweiss S, et al. “Antipsychotic Agents and Sudden Cardiac Death—How Should We Manage the Risk?” New England Journal of Medicine (Jan. 15, 2009): Vol. 360, No. 3, pp. 294–96. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19144946

Stroup TS, et al. “Results of Phase 3 of the CATIE Schizophrenia Trial,” Schizophrenia Research (Jan. 2009): Vol. 107, No. 1, pp. 1–12. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19027269

“Antipsychotic Drugs for Dementia: A Balancing Act,” Lancet Neurology (Feb. 2009): Vol 8, No. 2, p. 125.

Next Article: